Pediatric obesity and insulin resistance: Chronic disease risk and implications for treatment and prevention beyond body weight modification

被引:124
作者
Cruz, ML [1 ]
Shaibi, GQ
Weigensberg, MJ
Spruijt-Metz, D
Ball, GDC
Goran, MI
机构
[1] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90033 USA
[2] Univ So Calif, Dept Biokinesiol & Phys Therapy, Los Angeles, CA 90033 USA
[3] Univ So Calif, Dept Pediat, Los Angeles, CA 90033 USA
[4] Univ Alberta, Dept Pediat, Edmonton, AB 2C3 WMC, Canada
关键词
children; adiposity; insulin sensitivity;
D O I
10.1146/annurev.nutr.25.050304.092625
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The study of childhood obesity has continued to grow exponentially in the past decade. This has been driven in part by the increasing prevalence of this problem and the widespread potential effects of increased obesity in childhood on lifelong chronic disease risk. The focus of this review is on recent findings regarding the link between obesity and disease risk during childhood and adolescence. We describe recent reports relating to type 2 diabetes in youth (2), prediabetes (69, 166), metabolic syndrome (33, 35), polycystic ovarian syndrome (77), and nonalcoholic fatty liver disease (58, 146), and the mediating role of insulin resistance in these conditions. In addition, we review the implications of this research for the design of more effective treatment and prevention strategies that focus more on the improvement of obesity-related metabolic abnormalities and chronic disease risk reduction than on the conventional energy balance approach that focuses on weight management.
引用
收藏
页码:435 / 468
页数:34
相关论文
共 193 条
  • [1] INSULIN ENHANCEMENT OF LUTEINIZING-HORMONE AND FOLLICLE-STIMULATING-HORMONE RELEASE BY CULTURED PITUITARY-CELLS
    ADASHI, EY
    HSUEH, AJW
    YEN, SSC
    [J]. ENDOCRINOLOGY, 1981, 108 (04) : 1441 - 1449
  • [2] Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
  • [3] 2-S
  • [4] American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5
  • [5] IMPAIRED INSULIN ACTION IN PUBERTY - A CONTRIBUTING FACTOR TO POOR GLYCEMIC CONTROL IN ADOLESCENTS WITH DIABETES
    AMIEL, SA
    SHERWIN, RS
    SIMONSON, DC
    LAURITANO, AA
    TAMBORLANE, WV
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (04) : 215 - 219
  • [6] [Anonymous], 2000, Pediatrics, V105, P671
  • [7] Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone
    Antonucci, T
    Whitcomb, R
    McLain, R
    Lockwood, D
    [J]. DIABETES CARE, 1997, 20 (02) : 188 - 193
  • [8] Insulin secretion and sensitivity in black versus white prepubertal healthy children
    Arslanian, S
    Suprasongsin, C
    Janosky, JE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (06) : 1923 - 1927
  • [9] Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: Amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance
    Arslanian, SA
    Lewy, V
    Danadian, K
    Saad, R
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04) : 1555 - 1559
  • [10] Glucose intolerance in obese adolescents with polycystic ovary syndrome:: Roles of insulin resistance and β-cell dysfunction and risk of cardiovascular disease
    Arslanian, SA
    Lewy, VD
    Danadian, K
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (01) : 66 - 71